Molecular Quality Controls Market is expected to reach US$ 372.64 million by 2028

Published Date: 23 Jun 2021

Report : Molecular Quality Controls Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (Independent Controls and Instrument Specific Controls), Analyte Type (Single Analyte Controls and Multi Analyte Controls), Application (Infectious Diseases, Oncology, Genetic Testing, and Other Applications), and End User (Clinical Laboratories, Hospitals, IVD Manufacturers & Contract Research Organizations, Academic & Research Institutes, and Other End Users) and Geography

Infectious Diseases Segment to Hold Largest Market Share by Application During 2021–2028


According to our new research study on “Molecular Quality Controls Market Forecast to 2027 – COVID-19 Impact and Global Analysis – by Product, Application, Analyte Type and End User,” the market is expected to reach US$ 372.64 million in 2028 from US$ 184.62 million in 2021; it is estimated to grow at a CAGR of 10.6% during 2021–2028. The report highlights trends prevailing in the market and factors driving its growth. The growth of the molecular quality controls market is mainly attributed to the factors such as growing funds for genomics, declining cost of sequencing procedures, and increasing prevalence of genetic diseases fuel the growth of the market. However, the dearth of skilled professionals hinders the market growth.


Based on application, the molecular quality controls market is segmented into infectious diseases, oncology, genetic testing, and other applications. The infectious diseases segment held the largest share of the market in 2020, whereas the oncology segment is anticipated to register the highest CAGR in the market during the forecast period. Infectious diseases segment is expected to capture significant market share owing to high incidences of infectious disease outbreaks all over the world, technological advancements in molecular diagnostic testing and product developments by the market players. For instance, in 2018, Microbiologics Inc. launched 8 quality control products: Human Papillomavirus (HPV) Control Panel, Vaginal infection Control Panel, Blood Culture (BCID) Control Panel, Enteric Viral Control Panel and others.


Thermo Fisher Scientific Inc; Bio-Rad Laboratories Inc; F. Hoffmann la-Roche Ltd; Abbott; Quidel Corporation; Qnostics; Maine Molecular Controls Inc; Zeptometrix Corporation; Microbiologics, and Seracare Life Sciences are among the leading companies operating in the molecular quality controls market.


Molecular Quality Controls Market, by Region, 2020 (%)

Molecular Quality Controls Market, by Region, 2020 (%)


The report segments the molecular quality controls market as follows:


By Product

  • Independent Controls
  • Instrument Specific Controls

By Analyte Type

  • Single Analyte Controls
  • Multi Analyte Controls

By Application


  • Infectious Diseases
  • Oncology
  • Genetic Testing
  • Other Applications

By End User


  • Clinical Laboratories
  • Hospitals
  • IVD Manufacturers & Contract Research Organizations
  • Academic & Research Institutes
  • Other End Users

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id:   
Download Free PDF Brochure